Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional

Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

ClinicalTrials.gov ID: NCT01541670

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01541670. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and tolerability of Anti-MIF Antibody in subjects with lupus nephritis.

Study identification

NCT ID
NCT01541670
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
Baxalta now part of Shire
Industry
Enrollment
4 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2011 (Actual)
Primary completion
Dec 31, 2012 (Actual)
Completion
Dec 31, 2012 (Actual)
Last update posted
May 5, 2021

2011 – 2012

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Academic Medical Research Institute Inc. Los Angeles California 90022 —
Mohamed A. El-Shahawy Los Angeles California 90022 —
North Valley Nephrology Yuba City California 95991 —
IMMUNOe International Research Centers Centennial Colorado 80112 —
University of Colorado Denver Colorado 80220 —
Tulane University Hospital & Clinic New Orleans Louisiana 70112 —
Clinical Research Development Associates, LLC Springfield Gardens New York 11413 —
Northeast Clinical Research Center, LLC Bethlehem Pennsylvania 18017 —
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 —
Ramesh Gupta Memphis Tennessee 38016 —
Ramesh Gupta Memphis Tennessee 38119 —
UT Southwestern Medical Center at Dallas Dallas Texas 75390-8523 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01541670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2021 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.